SNGX RSI Chart
Last 7 days
-2.5%
Last 30 days
-23.5%
Last 90 days
-43.5%
Trailing 12 Months
-49.8%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 699.2K | 0 | 0 | 0 |
2023 | 1.0M | 996.3K | 960.6K | 839.4K |
2022 | 864.7K | 878.6K | 858.5K | 948.9K |
2021 | 1.6M | 1.3M | 869.4K | 824.3K |
2020 | 4.4M | 3.4M | 2.7M | 2.4M |
2019 | 5.3M | 5.1M | 5.0M | 4.6M |
2018 | 5.2M | 6.0M | 5.5M | 5.2M |
2017 | 0 | 8.1M | 7.3M | 5.4M |
2016 | 0 | 0 | 0 | 0 |
2015 | 0 | 0 | 0 | 0 |
2014 | 3.2M | 4.0M | 6.5M | 1.5M |
2013 | 3.2M | 3.2M | 2.8M | 3.2M |
2012 | 6.1M | 6.4M | 2.3M | 0 |
2011 | 3.0M | 4.1M | 5.1M | 6.2M |
2010 | 0 | 0 | 0 | 1.9M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 18, 2022 | schaber christopher j | bought | 8,866 | 0.4433 | 20,000 | chairman, ceo and president |
May 18, 2022 | straube richard | bought | 4,000 | 0.5 | 8,000 | senior vice president and cmo |
Dec 17, 2021 | schaber christopher j | bought | 5,179 | 0.7399 | 7,000 | chairman, ceo and president |
Dec 15, 2021 | guarino jonathan l. | bought | 700 | 0.7 | 1,000 | senior vice president and cfo |
Dec 14, 2021 | schaber christopher j | bought | 7,269 | 0.7269 | 10,000 | chairman, ceo and president |
Dec 14, 2021 | guarino jonathan l. | bought | 7,119 | 0.7119 | 10,000 | senior vice president and cfo |
May 14, 2021 | zeldis jerome b | sold | -2,700 | 0.9002 | -3,000 | - |
May 14, 2021 | zeldis jerome b | bought | 2,664 | 0.888 | 3,000 | - |
Nov 19, 2019 | schaber christopher j | bought | 10,016 | 0.93 | 10,770 | chairman, ceo and president |
Nov 19, 2019 | zeldis jerome b | bought | 1,850 | 0.925 | 2,000 | - |
Which funds bought or sold SNGX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | MORGAN STANLEY | reduced | -0.19 | -571 | 2,156 | -% |
May 15, 2024 | FIRST WILSHIRE SECURITIES MANAGEMENT INC | unchanged | - | -4,000 | 14,000 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | unchanged | - | -3.00 | 12.00 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 2.83 | -947 | 4,181 | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | new | - | 6,861 | 6,861 | -% |
May 15, 2024 | TWO SIGMA INVESTMENTS, LP | added | 8.5 | -1,246 | 7,639 | -% |
May 15, 2024 | NOMURA HOLDINGS INC | new | - | 18,000 | 18,000 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -13,435 | - | -% |
May 14, 2024 | NewEdge Advisors, LLC | reduced | -93.75 | -34.00 | 2.00 | -% |
May 13, 2024 | UBS Group AG | new | - | 857 | 857 | -% |
Unveiling Soligenix Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Soligenix Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Soligenix Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -52.2% | 117,029 | 244,812 | 130,440 | 206,929 | 257,178 | 366,068 | 166,140 | 228,640 | 188,063 | 275,653 | 186,198 | 214,824 | 147,593 | 320,795 | 608,811 | 505,288 | 924,552 | 685,261 | 1,254,904 | 1,544,964 | 1,144,788 |
Cost Of Revenue | -47.2% | 117,029 | 221,546 | 110,441 | 184,021 | 226,040 | 135,865 | 129,440 | 193,304 | 92,213 | 235,698 | 166,265 | 204,317 | 122,360 | 241,464 | 386,641 | 363,339 | 829,506 | 587,224 | 965,453 | 1,086,814 | 927,924 |
Gross Profit | -100.0% | - | 23,266 | 19,999 | 22,908 | 31,138 | 230,203 | 36,700 | 35,336 | 95,850 | 39,955 | 19,933 | 10,507 | 25,233 | 79,332 | 222,170 | 141,949 | 95,046 | 98,037 | 289,451 | 458,150 | 216,864 |
Operating Expenses | -2.0% | 2,117,091 | 2,161,137 | 1,799,055 | 1,653,232 | 2,181,827 | 3,800,181 | 3,117,944 | 3,430,632 | 4,288,236 | 4,551,738 | 3,384,844 | 2,999,166 | 2,258,840 | 5,565,399 | 2,034,947 | 2,955,821 | 8,568,838 | 3,407,505 | 3,056,050 | 2,623,041 | 2,516,927 |
S&GA Expenses | -100.0% | - | 1,383,603 | 973,040 | 890,533 | 1,235,376 | 1,442,394 | 1,326,249 | 1,382,793 | 2,541,468 | 1,849,583 | 1,147,279 | 1,062,558 | 949,318 | 1,905,975 | 768,420 | 785,776 | 868,667 | 1,048,362 | 789,251 | 769,091 | 874,209 |
R&D Expenses | 40.8% | 1,095,040 | 777,534 | 826,015 | 762,699 | 946,451 | 2,357,787 | 1,791,695 | 2,047,839 | 1,746,768 | 2,702,155 | 2,237,565 | 1,936,608 | 1,309,522 | 3,659,424 | 1,266,527 | 2,170,045 | 2,700,171 | 2,359,143 | 2,266,799 | 1,853,950 | 1,642,718 |
EBITDA Margin | -17.7% | -10.32 | -8.76 | -8.85 | -10.04 | -11.72 | -14.82 | -16.84 | -17.26 | -17.12 | -16.08 | -17.13 | -9.96 | -8.00 | -7.83 | - | - | - | - | - | - | - |
Interest Expenses | 0% | 64,047 | 64,047 | 63,351 | 211,170 | 213,490 | 213,490 | 211,170 | 208,850 | 223,901 | 768,836 | -216,800 | -214,750 | -213,505 | -35,332 | 486 | 2,017 | 21,947 | - | - | - | - |
Income Taxes | 100.0% | - | -606,606 | - | - | -1,161,197 | - | -1,154,935 | -1,154,935 | - | 431,305 | -864,742 | -864,742 | 2,132 | - | - | - | -836,893 | - | - | - | -610,676 |
Earnings Before Taxes | 21.1% | -1,915,327 | -2,426,501 | -1,662,702 | -1,612,024 | -2,207,306 | -3,753,555 | -3,309,003 | -3,541,695 | -4,349,021 | -4,703,876 | -3,587,551 | -2,761,810 | -2,362,478 | -5,540,265 | -1,790,160 | -2,776,763 | -8,418,227 | -2,871,661 | -2,720,783 | -2,123,521 | -2,250,303 |
EBT Margin | -15.6% | -10.89 | -9.42 | -9.61 | -10.92 | -12.58 | -15.76 | -18.52 | -18.42 | -17.81 | -16.28 | -16.39 | -9.64 | -7.88 | -7.85 | - | - | - | - | - | - | - |
Net Income | -5.2% | -1,915,327 | -1,819,895 | -1,662,702 | -1,612,024 | -1,046,109 | -3,753,555 | -3,309,003 | -2,386,760 | -4,349,021 | -4,703,876 | -3,587,551 | -1,897,068 | -2,362,478 | -5,540,265 | -1,790,160 | -2,776,763 | -7,581,334 | -2,871,661 | -2,720,783 | -2,123,521 | -1,639,627 |
Net Income Margin | -37.0% | -10.03 | -7.32 | -8.41 | -9.76 | -10.31 | -14.54 | -17.18 | -17.10 | -16.81 | -15.23 | -15.40 | -8.97 | -7.88 | -7.50 | - | - | - | - | - | - | - |
Free Cashflow | 26.6% | -1,342,482 | -1,828,213 | -2,686,316 | -1,923,327 | -2,166,253 | -3,627,141 | -3,254,977 | -2,528,060 | -3,238,843 | -3,055,354 | -3,040,119 | -1,658,920 | -3,985,227 | -4,124,955 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -17.7% | 8,058 | 9,797 | 11,303 | 13,826 | 11,102 | 14,280 | 17,947 | 21,312 | 23,675 | 26,870 | 29,718 | 29,610 | 31,552 | 19,891 | 13,250 | 12,261 | 9,848 | 7,775 | 8,332 | 9,193 | 9,521 |
Current Assets | -17.8% | 7,818 | 9,507 | 10,972 | 13,471 | 10,722 | 13,853 | 17,493 | 20,826 | 23,474 | 26,570 | 29,445 | 29,353 | 31,280 | 19,467 | 12,730 | 11,977 | 9,569 | 7,493 | 8,010 | 8,812 | 9,128 |
Cash Equivalents | -16.0% | 7,092 | 8,446 | 10,299 | 13,161 | 10,266 | 13,360 | 16,866 | 20,158 | 22,876 | 26,044 | 28,867 | 28,980 | 30,542 | 18,677 | 11,343 | 11,168 | 7,203 | 5,421 | 6,552 | 6,986 | 7,200 |
Net PPE | -13.3% | 10.00 | 12.00 | 14.00 | 15.00 | 17.00 | 18.00 | 22.00 | 26.00 | 28.00 | 22.00 | 14.00 | 17.00 | 20.00 | 24.00 | 28.00 | 33.00 | 38.00 | 36.00 | 10.00 | 12.00 | 16.00 |
Liabilities | 0.2% | 7,290 | 7,275 | 7,082 | 8,026 | 14,489 | 16,751 | 16,915 | 17,107 | 17,090 | 16,147 | 14,663 | 14,014 | 14,234 | 16,149 | 5,845 | 6,230 | 6,333 | 6,318 | 5,654 | 5,557 | 4,240 |
Current Liabilities | 17.2% | 7,211 | 6,152 | 5,522 | 5,758 | 11,377 | 16,517 | 9,666 | 8,840 | 7,224 | 6,291 | 4,796 | 4,125 | 4,301 | 6,081 | 5,536 | 5,996 | 6,329 | 6,312 | 5,634 | 5,500 | 4,148 |
Long Term Debt | -100.0% | - | 1,011 | 1,416 | 2,094 | 2,908 | - | 6,887 | 7,877 | 9,866 | 9,856 | 9,846 | 9,835 | 9,824 | 9,860 | - | - | - | - | - | - | - |
LT Debt, Current | 33.2% | 2,996 | 2,250 | 1,500 | 750 | 6,000 | 9,898 | 3,000 | 2,000 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -69.5% | 768 | 2,522 | 4,221 | 5,800 | -3,387 | -2,470 | 1,032 | 4,206 | 6,584 | 10,723 | 15,055 | 15,596 | 17,319 | 3,742 | 7,405 | 6,031 | 3,515 | 1,457 | 2,678 | 3,636 | 5,282 |
Retained Earnings | -0.8% | -227,619 | -225,704 | -223,884 | -222,221 | -220,609 | -219,563 | -215,809 | -212,500 | -210,114 | -205,765 | -201,061 | -197,473 | -195,576 | -193,214 | -187,673 | -185,883 | -183,106 | -175,525 | -172,653 | -169,933 | -167,809 |
Additional Paid-In Capital | 0.1% | 228,353 | 228,194 | 228,071 | 228,006 | 217,207 | 217,065 | 216,773 | 216,653 | 216,531 | 216,443 | 216,024 | 213,062 | 212,891 | 196,950 | 195,059 | 191,923 | 186,625 | 177,006 | 175,326 | 173,558 | 173,076 |
Accumulated Depreciation | -100.0% | - | 121 | 120 | 118 | 117 | 115 | 112 | 107 | 172 | 168 | 164 | 161 | - | 155 | - | - | - | - | - | - | - |
Shares Outstanding | 1.4% | 10,524 | 10,378 | 10,378 | 9,842 | 2,930 | 2,909 | 2,872 | 2,867 | 2,861 | 2,858 | 2,713 | 2,672 | 2,455 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 6,847 | - | - | - | 25,735 | - | - | - | 39,976 | - | - | - | 57,300 | - | - | - | 9,584 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 26.6% | -1,342 | -1,828 | -2,686 | -1,923 | -2,166 | -3,627 | -3,254 | -2,528 | -3,238 | -3,055 | -3,040 | -1,658 | -3,985 | -4,124 | -2,990 | -1,643 | -2,695 | -2,643 | -2,057 | -515 | -2,293 |
Share Based Compensation | -57.5% | 60.00 | 141 | 65.00 | 90.00 | 74.00 | 113 | 71.00 | 72.00 | 78.00 | 106 | 80.00 | 81.00 | 95.00 | 199 | 67.00 | 81.00 | 64.00 | 142 | 82.00 | 73.00 | 80.00 |
Cashflow From Investing | - | - | - | - | - | - | - | - | -3.25 | -9.82 | - | - | - | - | - | - | - | -7.15 | -30.21 | - | - | - |
Cashflow From Financing | 80.5% | -8.99 | -46.18 | -175 | 4,817 | -931 | - | - | - | - | 251 | 2,863 | 89.00 | 15,856 | 11,435 | 3,109 | 5,618 | 4,516 | 1,559 | 1,637 | 304 | 505 |
Condensed Consolidated Statements of Operations - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Total revenues | $ 117,029 | $ 257,178 |
Cost of revenues | (117,029) | (226,040) |
Gross profit | 31,138 | |
Operating expenses: | ||
Research and development | 1,095,040 | 946,451 |
General and administrative | 1,022,051 | 1,235,376 |
Total operating expenses | 2,117,091 | 2,181,827 |
Loss from operations | (2,117,091) | (2,150,689) |
Other income (expense): | ||
Foreign currency transaction gain (loss) | 1,209 | (366) |
Interest income (expense), net | 28,842 | (103,568) |
Research and development incentives | 6,331 | 6,448 |
Other income | 40,869 | |
Change in fair value of convertible debt | 165,382 | |
Total other income (expense) | 201,764 | (56,617) |
Net loss before income taxes | (1,915,327) | (2,207,306) |
Income tax benefit | 1,161,197 | |
Net loss applicable to common stockholders | $ (1,915,327) | $ (1,046,109) |
Basic net loss per share (in Dollars per share) | $ (0.18) | $ (0.36) |
Diluted net loss per share (in Dollars per share) | $ (0.18) | $ (0.36) |
Basic weighted average common shares outstanding (in Shares) | 10,521,233 | 2,914,929 |
Diluted weighted average common shares outstanding (in Shares) | 10,521,233 | 2,914,929 |
Grant revenue | ||
Total revenues | $ 117,029 | $ 257,178 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 7,091,548 | $ 8,446,158 |
Contracts and grants receivable | 117,029 | |
Unbilled revenue | 171,254 | |
Research and development incentives receivable, current | 25,253 | 23,894 |
Deferred issuance cost | 132,681 | |
Prepaid expenses and other current assets | 451,876 | 866,014 |
Total current assets | 7,818,387 | 9,507,320 |
Security deposit | 22,777 | 22,777 |
Office furniture and equipment, net | 10,339 | 11,927 |
Right-of-use lease assets | 200,569 | 229,834 |
Research and development incentives receivable, net of current portion | 6,313 | 25,468 |
Total assets | 8,058,385 | 9,797,326 |
Current liabilities: | ||
Accounts payable | 1,436,728 | 1,111,226 |
Accrued expenses | 2,602,665 | 2,418,002 |
Accrued compensation | 50,216 | 251,115 |
Lease liabilities, current | 125,143 | 121,765 |
Convertible debt | 2,996,136 | 2,250,000 |
Total current liabilities | 7,210,888 | 6,152,108 |
Non-current liabilities: | ||
Convertible debt | 1,010,934 | |
Lease liabilities, net of current portion | 79,125 | 111,862 |
Total liabilities | 7,290,013 | 7,274,904 |
Commitments and contingencies (Note 6) | ||
Shareholders' equity: | ||
Preferred stock, 350,000 shares authorized; none issued or outstanding at March 31, 2024 and December 31, 2023, respectively | 0 | 0 |
Common stock, $.001 par value; 75,000,000 shares authorized; 10,524,437 and 10,378,238 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 10,524 | 10,378 |
Additional paid-in capital | 228,353,208 | 228,193,977 |
Accumulated other comprehensive income | 24,143 | 22,243 |
Accumulated deficit | (227,619,503) | (225,704,176) |
Total shareholders' equity | 768,372 | 2,522,422 |
Total liabilities and shareholders' equity | $ 8,058,385 | $ 9,797,326 |